These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873 [TBL] [Abstract][Full Text] [Related]
4. Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia? Styczynski J; Wysocki M J Clin Oncol; 2004 Mar; 22(5):963-4. PubMed ID: 14990658 [No Abstract] [Full Text] [Related]
5. [The regimen for corticosteroid use in acute lymphoblastic leukemia]. Rass IT Ter Arkh; 1990; 62(7):155-7. PubMed ID: 2251658 [No Abstract] [Full Text] [Related]
6. Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids. Lönnerholm G; Nordgren A; Frost BM; Jonsson OG; Kanerva J; Nygaard R; Schmiegelow K; Larsson R; Forestier E Leukemia; 2009 Jan; 23(1):209-12. PubMed ID: 18615108 [No Abstract] [Full Text] [Related]
7. [Acute lymphoblastic leukemia and pregnancy. Apropos of a case]. Hamdoun L; Zeineb NB; Ferchiou M; Zhioua F; Meriah S Bull Cancer; 1992; 79(3):301-3. PubMed ID: 1392170 [TBL] [Abstract][Full Text] [Related]
8. [Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children]. Astruc D; Nowak V; Grunebaum L; Wiesel ML; Cazenave JP; Babin-Boilletot A; Lutz P Arch Pediatr; 1994 Jun; 1(6):617-8. PubMed ID: 7994359 [No Abstract] [Full Text] [Related]
12. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836 [TBL] [Abstract][Full Text] [Related]
13. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449 [TBL] [Abstract][Full Text] [Related]
14. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752 [TBL] [Abstract][Full Text] [Related]
15. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108 [TBL] [Abstract][Full Text] [Related]